EndoscopyNow vs myFibroScan

EndoscopyNow facilitates education in endoscopy through a comprehensive mobile platform showcasing the latest research, news, procedural techniques, and devices relevant to medical professionals. Our newsfeed and library offer a comprehensive set of content, including videos, journal articles, news, and training events aimed at providing an engaging and educational experience for all interested in endoscopy. Join EndoscopyNow so you can: Discover Content Personalized to You - Stay up to date with daily journal articles, news stories, and procedural videos personalized to your specialty and interests. Search an Expansive Library of Content: Our continuously refreshing up to date database of articles and videos is at your fingertips. You can search and filter these based on content types and your areas of interest. Pin Content for Future Reading (Pinned) - Easily save content you're interested in for later review. Everyday Practice Tools to Improve Patient Care - Educate and engage patients about their conditions and procedures using interactive drawings you create within our app. This DrawMD integration is as simple as choosing a template, annotating with a wide range of stamps, personalizing with text, and then sharing your drawings with your patients via email or print! Find Live Training Events - Discover and register for live training events that are happening in the app!

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.